158 related articles for article (PubMed ID: 26169354)
1. CIN85 modulates TGFβ signaling by promoting the presentation of TGFβ receptors on the cell surface.
Yakymovych I; Yakymovych M; Zang G; Mu Y; Bergh A; Landström M; Heldin CH
J Cell Biol; 2015 Jul; 210(2):319-32. PubMed ID: 26169354
[TBL] [Abstract][Full Text] [Related]
2. APPL proteins promote TGFβ-induced nuclear transport of the TGFβ type I receptor intracellular domain.
Song J; Mu Y; Li C; Bergh A; Miaczynska M; Heldin CH; Landström M
Oncotarget; 2016 Jan; 7(1):279-92. PubMed ID: 26583432
[TBL] [Abstract][Full Text] [Related]
3. RanBPM interacts with TβRI, TRAF6 and curbs TGF induced nuclear accumulation of TβRI.
Zhang J; Ma W; Tian S; Fan Z; Ma X; Yang X; Zhao Q; Tan K; Chen H; Chen D; Huang BR
Cell Signal; 2014 Jan; 26(1):162-72. PubMed ID: 24103590
[TBL] [Abstract][Full Text] [Related]
4. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
[TBL] [Abstract][Full Text] [Related]
5. TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor through polyubiquitination and activation of presenilin 1.
Gudey SK; Sundar R; Mu Y; Wallenius A; Zang G; Bergh A; Heldin CH; Landström M
Sci Signal; 2014 Jan; 7(307):ra2. PubMed ID: 24399296
[TBL] [Abstract][Full Text] [Related]
6. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction.
McLean S; Bhattacharya M; Di Guglielmo GM
Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267
[TBL] [Abstract][Full Text] [Related]
7. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
[TBL] [Abstract][Full Text] [Related]
8. TGFβ-induced invasion of prostate cancer cells is promoted by c-Jun-dependent transcriptional activation of Snail1.
Thakur N; Gudey SK; Marcusson A; Fu JY; Bergh A; Heldin CH; Landström M
Cell Cycle; 2014; 13(15):2400-14. PubMed ID: 25483191
[TBL] [Abstract][Full Text] [Related]
9. Non-Smad signaling pathways.
Mu Y; Gudey SK; Landström M
Cell Tissue Res; 2012 Jan; 347(1):11-20. PubMed ID: 21701805
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability.
Porsch H; Mehić M; Olofsson B; Heldin P; Heldin CH
J Biol Chem; 2014 Jul; 289(28):19747-57. PubMed ID: 24860093
[TBL] [Abstract][Full Text] [Related]
11. TbetaRI/Alk5-independent TbetaRII signaling to ERK1/2 in human skin cells according to distinct levels of TbetaRII expression.
Bandyopadhyay B; Han A; Dai J; Fan J; Li Y; Chen M; Woodley DT; Li W
J Cell Sci; 2011 Jan; 124(Pt 1):19-24. PubMed ID: 21172820
[TBL] [Abstract][Full Text] [Related]
12. TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor.
Sundar R; Gudey SK; Heldin CH; Landström M
Cell Cycle; 2015; 14(4):554-65. PubMed ID: 25622187
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
14. The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway.
Hocevar BA; Smine A; Xu XX; Howe PH
EMBO J; 2001 Jun; 20(11):2789-801. PubMed ID: 11387212
[TBL] [Abstract][Full Text] [Related]
15. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
16. aPKC alters the TGFβ response in NSCLC cells through both Smad-dependent and Smad-independent pathways.
Gunaratne A; Chan E; El-Chabib TH; Carter D; Di Guglielmo GM
J Cell Sci; 2015 Feb; 128(3):487–98. PubMed ID: 25501807
[TBL] [Abstract][Full Text] [Related]
17. TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer.
Mu Y; Sundar R; Thakur N; Ekman M; Gudey SK; Yakymovych M; Hermansson A; Dimitriou H; Bengoechea-Alonso MT; Ericsson J; Heldin CH; Landström M
Nat Commun; 2011; 2():330. PubMed ID: 21629263
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
19. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.
Sorrentino A; Thakur N; Grimsby S; Marcusson A; von Bulow V; Schuster N; Zhang S; Heldin CH; Landström M
Nat Cell Biol; 2008 Oct; 10(10):1199-207. PubMed ID: 18758450
[TBL] [Abstract][Full Text] [Related]
20. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.
Hayashi H; Abdollah S; Qiu Y; Cai J; Xu YY; Grinnell BW; Richardson MA; Topper JN; Gimbrone MA; Wrana JL; Falb D
Cell; 1997 Jun; 89(7):1165-73. PubMed ID: 9215638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
